 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience PR Newswire CINCINNATI and SEOUL, South Korea, Jan. 31, 2023 CINCINNATI and SEOUL, South Korea, Jan. 31, 2023 /PRNewswire/ --Meridian...

SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience

VIVO's total volume now sits at 6.4M. The +0.62% average daily price change was insignificant these 4 days, leaving VIVO's price at $33.97...

The volume for Meridian Bioscience stock increased for four consecutive days, resulting in a record-breaking daily growth of 441% of the 65-Day Volume Moving Average

VIVO's total volume now sits at 1.2M. The +0.62% average daily price change was insignificant these 3 days, leaving VIVO's price at $33.97...

The volume for Meridian Bioscience stock increased for three consecutive days, resulting in a record-breaking daily growth of 270% of the 65-Day Volume Moving Average

Meridian Bioscience, Inc. (NASDAQ:VIVO  Get Rating) shares saw unusually-high trading volume on Wednesday . Approximately 960,729 shares traded hands during trading, an increase of 106% from the previous sessions volume of 467,327 shares.The stock last traded at $33.94 and had ...

Meridian Bioscience (NASDAQ:VIVO) Sees Large Volume Increase

VIVO's total volume now sits at 2.2M. The +0.56% price change was insignificant, leaving IBM's price at $33.95...

The volume for Meridian Bioscience stock increased for one day, resulting in a record-breaking daily growth of 369% of the 65-Day Volume Moving Average

This is a signal that VIVO's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Meridian Bioscience (VIVO, $33.95) RSI Indicator left the overbought zone on January 25, 2023

DoubleVerify Holdings to Join S&P SmallCap 600 DoubleVerify Holdings to Join S&P SmallCap 600 PR Newswire NEW YORK, Jan. 25, 2023 NEW YORK, Jan. 25, 2023 /PRNewswire/ -- DoubleVerify Holdings Inc. (NYSE: DV) will replace Meridian Bioscience Inc. (NASD: VIVO) in the S&P...

DoubleVerify Holdings to Join S&P SmallCap 600

Royce  Associates LP reduced its position in Meridian Bioscience, Inc. (NASDAQ:VIVO  Get Rating) by 89.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 169,169 shares of the companys ...

Royce & Associates LP Decreases Holdings in Meridian Bioscience, Inc. (NASDAQ:VIVO)

Meridian Bioscience (VIVO, $33.74) RSI Indicator left the overbought zone on January 20, 2023

Meridian Bioscience (VIVO, $33.65) RSI Indicator left the overbought zone on January 19, 2023

Meridian Bioscience is an integrated life science company. The Company is engaged in developing, manufacturing, selling, and distributing clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics, and Life Science.

Watchers	1,556
52-Wk Low	$21.09
52-Wk High	$34.38

Market Cap	$1.49B
Volume (M)	487,702.00
52-Wk High	$34.38
52-Wk Low	$21.09

Current Price	$33.98
Prev Close	$33.97
Open	$33.95
Dividend Yield	0.00%
50-Day Moving Average	$32.94
Beta	0.62
Avg. Volume	700,349.81
PE Ratio	35.49

52-Week High	$34.38
52-Week Low	$21.09
Market Capitalization	$1.49B
EPS	-$0.0706
Price to Book	4.04
Revenue Per Employee	$585,590.29
Enterprise Value/EBITDA	18.22

VIVO Meridian Bioscience Inc.

About

Feed

News

Fundamentals